Nutex HealthNASDAQ: NUTX

HOUSTON , Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET.

Shares of Nutex Health Inc (NUTX, Financial) surged 5.48% in mid-day trading on Oct 2. The stock reached an intraday high of $21.86, before settling at $21.69, up from its previous close of $20.56.

Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho , Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho.

Nutex Health (NASDAQ:NUTX ) Q2 2024 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Jennifer Rodriguez - Investor Relations Manager Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Operator Greetings, and welcome to Nutex Health Second Quarter 2024 Financial Results Conference Call. At this time, all participants are on a listen-only mode.

TOTAL REVENUE OF $143.5 MILLION FOR THE FIRST HALF 2024 VS $115.3 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 81,276 FOR THE FIRST HALF 2024 VS VISITS OF 65,244 FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION OPERATING INCOME OF $33.3 MILLION FOR THE FIRST HALF 2024 VS $13.9 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 140% NET CASH FROM OPERATING ACTIVITIES OF $16.3 MILLION FOR THE FIRST HALF 2024 COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOW HOUSTON , Aug. 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in nine states and primary care-centric, risk-bearing physician networks, today announced second quarter 2024 financial results for the three and six months ended June 30, 2024. Financial Highlights for the Three Months Ended June 30, 2024: Total revenue of $76.1 million as compared to total revenue of $58.9 million for the three months ended June 30, 2023, an increase of 29%.

HOUSTON , Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET.

HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, announced today that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market as required by the Hearing Panel's June 14, 2024 decision, as previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024.

HOUSTON , June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024.  The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306.

COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 HOUSTON , June 19, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16. On June 14, 2024, the Company received notice from the Nasdaq Stock Market LLC ("Nasdaq") that a Nasdaq Hearings Panel had granted the Company an exception until July 22, 2024 to effect a reverse stock split of its common stock once approved by its Board of Directors and the Company's stockholders.